A number of firms have modified their ratings and price targets on shares of Syndax Pharmaceuticals (NASDAQ: SNDX) recently: 8/14/2017 – Syndax Pharmaceuticals had its “buy” rating reaffirmed by analysts at Instinet. They now have a $22.00 price target on the stock, down previously from $27.00. 8/11/2017 – Syndax Pharmaceuticals had its price target raised […]
